Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance

References

• Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102 (2651):400-1; PMID:17755278; http://dx.doi.org/10.1126/science.102.2651.400
   PubMed Web of Science ®Google Scholar
• Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172 (4379):603-7; PMID:13099277; http://dx.doi.org/10.1038/172603a0
   PubMed Web of Science ®Google Scholar
• Orlando G, Hematti P, Stratta RJ, Burke GW 3rd, Di Cocco P, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 2010; 252 (6):915-28; PMID:21107102; http://dx.doi.org/10.1097/SLA.0b013e3181f3efb0
   PubMed Web of Science ®Google Scholar
• Girmanova E, Hruba P, Viklicky O. Circulating biomarkers of tolerance. Transplant Rev 2015; 29 (2):68-72; PMID:25636718; http://dx.doi.org/10.1016/j.trre.2015.01.003
   PubMed Web of Science ®Google Scholar
• Ashton-Chess J, Giral M, Brouard S, Soulillou JP. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 2007; 84(10):1215-9; PMID:18049104; http://dx.doi.org/10.1097/01.tp.0000290683.54937.1b
   PubMed Web of Science ®Google Scholar
• Xu H, Ildstad ST. Transplantation: Is donor T-cell engraftment a biomarker for tolerance? Nat Rev Nephrol 2012; 8 (10):560-1; PMID:22868709; http://dx.doi.org/10.1038/nrneph.2012.187
   PubMed Web of Science ®Google Scholar
• Shapiro R, Zeevi A, Basu A, Tan HP, Kayler LK, Blisard DM, Thai NL, Girnita AL, Randhawa PS, Gray EA, et al. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008; 85 (8):1125-32; PMID:18431232; http://dx.doi.org/10.1097/TP.0b013e31816a8a6d
   PubMed Web of Science ®Google Scholar
• Hoshino J, Kaneku H, Everly MJ, Greenland S, Terasaki PI. Using donor-specific antibodies to monitor the need for immunosuppression. Transplantation 2012; 93 (11):1173-8; PMID:22592887; http://dx.doi.org/10.1097/TP.0b013e31824f3d7c
   PubMed Web of Science ®Google Scholar
• Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, et al. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant 2014; 14 (7):1599-611; PMID:24903438; http://dx.doi.org/10.1111/ajt.12731
   PubMed Web of Science ®Google Scholar
• Elias N, Cosimi AB, Kawai T. Clinical trials for induction of renal allograft tolerance. Curr.Opin.Organ Transplant. 2015; 20 (4):406-411; PMID:26147679; http://dx.doi.org/10.1097/MOT.0000000000000211
   PubMed Web of Science ®Google Scholar
• Scandling JD, Busque S, Shizuru JA, Lowsky R, Hoppe R, Dejbakhsh-Jones S, Jensen K, Shori A, Strober JA, Lavori P, et al. Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant 2015; 15 (3):695-704; PMID:25693475; http://dx.doi.org/10.1111/ajt.13091
   PubMed Web of Science ®Google Scholar
• Tonsho M, Lee S, Aoyama A, Boskovic S, Nadazdin O, Capetta K, Smith RN, Colvin RB, Sachs DH, Cosimi AB, et al. Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism. Am J Transplant 2015; 15(8):2231-9; PMID:25904524; http://dx.doi.org/10.1111/ajt.13274
   PubMed Web of Science ®Google Scholar
• Yamada Y, Nadazdin O, Boskovic S, Lee S, Zorn E, Smith RN, Colvin RB, Madsen JC, Cosimi AB, Kawai T, Benichou G. Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys. Am J Transplant. 2015 Jul 17; 15(12):3055-66; [Epub ahead of print] PMID: 26190648.
   PubMed Web of Science ®Google Scholar
• Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307 (5947):168-70; PMID:6361574; http://dx.doi.org/10.1038/307168a0
   PubMed Web of Science ®Google Scholar
• Fuchs EJ, Huang XJ, Miller JS. HLA-haploidentical stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2010; 16 (1 Suppl): S57-S63; PMID:19892024; http://dx.doi.org/10.1016/j.bbmt.2009.10.032
   PubMedGoogle Scholar
• Colson YL, Shinde Patil VR, Ildstad ST. Facilitating cells: Novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD. Crit Rev Oncol Hematol 2007; 61 (1):26-43; PMID:17150368; http://dx.doi.org/10.1016/j.critrevonc.2006.06.011
   PubMed Web of Science ®Google Scholar
• Sharabi Y, Sachs DH.. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. Journal of Experimental Medicine 1989; 169:493-502; PMID:2562984; http://dx.doi.org/10.1084/jem.169.2.493
   PubMed Web of Science ®Google Scholar
• Gandy KL, Domen J, Aguila H, Weissman IL. CD8+TCR+ and CD8+TCR− cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 1999; 11 (5):579-90; PMID:10591183; http://dx.doi.org/10.1016/S1074-7613(00)80133-8
   PubMed Web of Science ®Google Scholar
• Kaufman CL, Ildstad ST. Induction of donor-specific tolerance by transplantation of bone marrow. Ther Immunol 1994; 1(2):101-11; PMID:7584482.
   PubMedGoogle Scholar
• Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84 (8):2436-46; PMID:7919363.
   PubMed Web of Science ®Google Scholar
• Rezzoug F, Huang Y, Tanner MK, Wysoczynski M, Schanie CL, Chilton PM, Ratajczak MZ, Fugier-Vivier IJ, Ildstad ST. TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol 2008; 180 (1):49-57; PMID:18097003; http://dx.doi.org/10.4049/jimmunol.180.1.49
   PubMed Web of Science ®Google Scholar
• Fugier-Vivier IJ, Rezzoug F, Huang Y, Graul-Layman AJ, Schanie CL, Xu H, Chilton PM, Ildstad ST. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med 2005; 201 (3):373-83; PMID:15699072; http://dx.doi.org/10.1084/jem.20041399
   PubMed Web of Science ®Google Scholar
• Wen Y, Elliott MJ, Huang Y, Miller TO, Corbin DR, Hussain LR, Ratajczak MZ, Fukui Y, Ildstad ST. DOCK2 is critical for CD8+TCR− graft facilitating cells to enhance engraftment of hematopoietic stem and progenitor cells. Stem Cells 2014; 32(10):2732-43; PMID:25044556; http://dx.doi.org/10.1002/stem.1780
   PubMed Web of Science ®Google Scholar
• Huang Y, Bozulic LD, Miller T, Xu H, Hussain LR, Ildstad ST. CD8α+ plasmacytoid precursor DC induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo. Blood 2011; 117 (8):2494-505; PMID:21190989; http://dx.doi.org/10.1182/blood-2010-06-291187
   PubMed Web of Science ®Google Scholar
• Taylor KN, Shinde-Patil VR, Cohick E, Colson YL. Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells. J Immunol 2007; 179 (4):2153-62; PMID:17675474; http://dx.doi.org/10.4049/jimmunol.179.4.2153
   PubMed Web of Science ®Google Scholar
• Huang Y, Elliott MJ, Yolcu ES, Miller TO, Ratajczak J, Bozulic LD, Wen Y, Xu H, Ratajczak MZ, Ildstad ST. Characterization of human CD8+TCR− facilitating cells in vitro and in vivo in a NOD/SCID/IL2rγnull mouse model. Am J Transplant 2015; [Epub ahead of print] PMID: 26550777.
   PubMed Web of Science ®Google Scholar
• Ildstad ST, Crilley PA, Kaufman CL, Tollerud DJ, Cerrito P, Perry T, Shadduck RK, Lister J, Champlin RJ, Wingard JR, et al. A graft engineering method to allow bone marrow transplantation (BMT) for more hightly mismatched recipients with leukemia: Multivariate analysis of a Phase I/II protocol. Transplantation 2010; 4:S294.
   Google Scholar
• Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, King B, Elliott MJ, Herzig G, Herzig R, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4:124ra28; PMID:22399264; http://dx.doi.org/10.1126/scitranslmed.3003509
   PubMed Web of Science ®Google Scholar
• Leventhal JR, Elliott MJ, Yolcu ES, Bozulic LD, Tollerud DJ, Mathew JM, Konieczna I, Ison MG, Galvin J, Mehta J, et al. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation 2015; 99:288-98; PMID:25594553; http://dx.doi.org/10.1097/TP.0000000000000605
   PubMed Web of Science ®Google Scholar
• Leventhal J, Abecassis M, Miller J, Gallon L, Tollerud D, Elliott MJ, Bozulic LD, Houston C, Sustento-Reodica N, Ildstad ST. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation 2013; 95:169-76; PMID:23222893; http://dx.doi.org/10.1097/TP.0b013e3182782fc1
   PubMed Web of Science ®Google Scholar
• Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med 2013; 5:179ps7; PMID:23552369; http://dx.doi.org/10.1126/scitranslmed.3005568
   PubMed Web of Science ®Google Scholar